#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma Albright's disease Demyelination Aplastic anaemia Bronchiectasis Diffuse large B-cell lymphoma refractory Hereditary optic atrophy Immunodeficiency Isodicentric chromosome 15 syndrome Leukocyte adhesion deficiency Warm autoimmune haemolytic anaemia Oesophageal adenocarcinoma stage III Ewing's sarcoma Undifferentiated sarcoma Acute myeloid leukaemia refractory More trials…

    Learn about Rare Diseases

    Medulloblastoma – Basic Information Breast angiosarcoma – Trials in Disease Pemphigoid – Trials in Disease Chondrosarcoma metastatic – Trials in Disease Inclusion body myositis – Diagnostics SAPHO syndrome Cholangitis sclerosing – Treatment Antithrombin III deficiency Haemophilia A without inhibitors – Trials in Disease Glomerulonephritis rapidly progressive – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Viltolarsen Lomustine Perindopril Arginine Dapansutrile Fosfomycin Trometamol OMECAMTIV MECARBIL Deferiprone F770/05 Cabazitaxel Foscarnet Sodium Hexahydrate Lorlatinib Thiopental Sodium Patiromer VOROLANIB Specific Nucleic Acid Sna-Xfsc Anifrolumab Abemaciclib Mva-209-Fsp-B3 Neflamapimod Thiamine More therapies…

    Learn about Your Condition

    Extra-osseous Ewing's sarcoma Tetanus Diabetic gastroparesis ROHHAD syndrome Tympanic membrane perforation Short-bowel syndrome Ventricular tachycardia Radicular pain Mesothelioma malignant Otitis media Stomatitis Demyelination Synovial sarcoma Fibrosarcoma Exposure via breast milk More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Riociguat and Macitentan in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Macitentan
    France

  • Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Metastases to liver
    Investigated Drugs:
    • Oxaliplatin
    Belgium France

  • Study comparing dexamethasone versus immunoglobulin plus prednisone for adults with immune thrombocytopenia (ITP) who have moderate to severe bleeding

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Dexamethasone
    • Human Normal Immunoglobulin (Iv)
    • Prednisolone
    France

  • Study on Bepirovirsen for Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    Bulgaria France Germany Greece Hungary Italy +3

  • Study on Tralokinumab for Moderate-to-Severe Atopic Hand Eczema in Patients Needing Systemic Therapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tralokinumab
    Belgium Czechia France Germany The Netherlands Poland +3

  • Study on Methotrexate, Dexamethasone, and Montelukast to Prevent Infusion Reactions in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Amivantamab
    • Dexamethasone
    • Lazertinib
    France Spain

  • Study on Efgartigimod Alfa and Prednisone for Adults with Bullous Pemphigoid

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Pemphigoid
    Investigated Drugs:
    • Efgartigimod Alfa
    • Prednisone
    Bulgaria Croatia Czechia France Germany Greece +8

  • Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Anhydrous Docetaxel
    • Betamethasone Sodium Phosphate Ph. Eur
    Czechia France Germany Greece Italy Poland +1

  • Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Diphenhydramine Hydrochloride
    • Methylprednisolone
    • Ocrelizumab
    Belgium Denmark France Germany Greece Hungary +4

  • Study on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Omalizumab
    • Remibrutinib
    Bulgaria Czechia France Germany Hungary Italy +4
Previous Page
1 … 35 36 37 38 39 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!